---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-024697"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:43:04.871940+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Finch Therapeutics posts updated corporate presentation to website on November 14, 2022

## Summary
- Updated corporate presentation posted on November 14, 2022 under 'Events & Presentations' section of Finch's website.
- Presentation covers general business update and microbiome pipeline; no specific financial or clinical data disclosed.
- No earnings, guidance, or material operational milestones announced in this 8-K.

## SEC filing metadata
- accession: 0000950170-22-024697
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000095017022024697/0000950170-22-024697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000095017022024697/fnch-20221114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-024697
- JSON: https://secwatch.observer/filing/0000950170-22-024697.json
- Plain text: https://secwatch.observer/filing/0000950170-22-024697.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.